AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme

NCT00107237 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: AEE788
DRUG: everolimus

Sponsor

Novartis Pharmaceuticals